JPS56166115A - Carcinostatic agent - Google Patents
Carcinostatic agentInfo
- Publication number
- JPS56166115A JPS56166115A JP6883980A JP6883980A JPS56166115A JP S56166115 A JPS56166115 A JP S56166115A JP 6883980 A JP6883980 A JP 6883980A JP 6883980 A JP6883980 A JP 6883980A JP S56166115 A JPS56166115 A JP S56166115A
- Authority
- JP
- Japan
- Prior art keywords
- agent
- carcinostatic
- action
- formula
- active constituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE: A carcinostatic agent, containing a specific chlorinated phenothiazine derivative as an active constituent, and capable of exhibiting a strong inhibitory action particularly on a solid tumor with high safety.
CONSTITUTION: A carcinostatic agent containing a chlorinated phenothiazine derivative of formula I or II (Y is H or acetyl) as an active constituent. Some of the compounds expressed by formula I or II are known to have a pharmacological action as a psychotropic agent, however, have a strong carcinostatic action on a solid cancer regardless of the pharmacological activity as the psychotropic agent with low toxicity without side effects on autonomic nervous diseases or central nervous system and are highly safe. The agent is administered in a dose of 50W2,000mg per day for an adult by the oral route or injection.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6883980A JPS56166115A (en) | 1980-05-26 | 1980-05-26 | Carcinostatic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6883980A JPS56166115A (en) | 1980-05-26 | 1980-05-26 | Carcinostatic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS56166115A true JPS56166115A (en) | 1981-12-21 |
Family
ID=13385257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6883980A Pending JPS56166115A (en) | 1980-05-26 | 1980-05-26 | Carcinostatic agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56166115A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5371081A (en) * | 1991-08-12 | 1994-12-06 | St. Jude Children's Research Hospital | N-substituted phenoxazines for treating multidrug resistant cancer cells |
-
1980
- 1980-05-26 JP JP6883980A patent/JPS56166115A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5371081A (en) * | 1991-08-12 | 1994-12-06 | St. Jude Children's Research Hospital | N-substituted phenoxazines for treating multidrug resistant cancer cells |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2416012A1 (en) | DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES | |
EP0056379A4 (en) | Controlled release compositions for administration of therapeutic agents to ruminants. | |
ES8100883A1 (en) | Transdermal medication system for isosorbide dinitrate | |
JPS5630917A (en) | Preventive and remedy for hepatitis | |
JPS5489036A (en) | Remedy and preventive for hypersensitivity to light | |
JPS56166115A (en) | Carcinostatic agent | |
IE821258L (en) | Anti-herpes medicaments | |
JPS57106618A (en) | Anticancer agent consisting of polyprenyl compound | |
JPS5470428A (en) | Carcinostatic agent | |
JPS5791922A (en) | Antiviral agent of external use | |
IE852850L (en) | Anticoccidial compositions | |
Viukari et al. | Effect of methyldopa on tardive dyskinesia in psychogeriatric patients. | |
GB1460325A (en) | Pharmaceutical composition intended for relieving pain and producing analgesia | |
DE3163920D1 (en) | Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases | |
JPS55113721A (en) | Immunity regulator | |
JPS5742620A (en) | Novel antiulcer agent | |
JPS5639019A (en) | Antiviral agent | |
JPS5569510A (en) | Carcinostatic agent | |
JPS5716821A (en) | Remedy for disease due to immunological dysfunction | |
JPS5718618A (en) | Antitumor agent | |
JPS57126422A (en) | Stabilizing method of lysozyme pharmaceutical | |
JPS5498339A (en) | Carcinostatic agent | |
JPS57108013A (en) | Antibacterial agent | |
JPS57128625A (en) | Carcinostatic | |
JPS57179118A (en) | Antitumor agent |